Emerging Technologies to Reduce the Cost and Risk of Dementia

Join the ILTCI, Neurotrack, and the Milken Institute's Center for the Future of Aging for this exclusive webinar.

OVERVIEW
This session will provide a unique perspective on today’s “state of the union” surrounding cognitive health, the future of cognitive testing, and what can be done to reduce long-term disease risk.

MODERATOR
John O’Leary, MBA, President
O’Leary Marketing Associates LLC

SPEAKERS
Rajiv Ahuja, JD, Associate Director at the Milken Institute’s Center for the Future of Aging, will provide an overview and key findings from the recently released Milken report “Reducing the Cost and Risk of Dementia.” He will focus on data and findings from that report that deal with the key role of early identification in cognitive decline, and the importance of early intervention in treatments.

John Harrison, PhD, Associate Professor at Alzheimer Center Amsterdam and member of Neurotrack's Scientific Advisory Board, will review current practice with a focus on the limitations of standard methods of assessment. John will describe recent developments and in particular the welcome move to digital assessment. He will conclude with a vision of how we can employ digital assessment to inform clinical management, reduce healthcare costs and empower individuals to manage their cognitive health.

Jordan Glenn, PhD, Vice President of Clinical Development at Neurotrack, a Silicon Valley based start-up, will discuss the latest in technological innovation, focusing on early assessments of brain health using eye movement technologies and multi-modal lifestyle interventions such as exercise, diet, sleep, stress reduction and socialization to potentially mitigate or delay the onset of Alzheimer’s and other dementia-related diseases.

01:03:00